Distinct Antiviral Properties of Two Different Bacterial Lysates

Figure 4

Modification of β-defensin-1 and IFN-β by bacterial lysates. β-defensin-1 release by BEAS-2B and primary cells infected with 1.0 MOI RV-16 after pretreatment with (a) OM-85 or (b) Pulmonarom at different concentrations after 24 hours. IFN-β release by BEAS-2B and primary cells infected by 1.0 MOI RV-16 and pretreated with increasing concentrations of either (c) OM-85 or (d) Pulmonarom.

(a)

(b)

(c)

(d)